Annals of Nuclear Medicine

Aims & Scope

Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine (JSNM) whose main aim is to develop the appropriate application of radioactive substances and stable nuclides in the field of medicine.

To that end, this journal promotes the exchange of ideas and information and research in nuclear medicine as well.

Papers on the medical application of radionuclides and related subjects are welcomed.

Four types of papers are considered for publication: original articles, short communications, reviews, letters to the editor, and others.

Submitted manuscripts are reviewed in terms of originality, significance, and adequacy of documentation.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	2.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.661

Quartile

Year	Value
2024	Q2

Journal Rank

Year	Value
2024	8666

Journal Citation Indicator

Year	Value
2024	803

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology

  Citation: 217

  Authors: Kazuo

• PET studies in dementia

  Citation: 164

  Authors: Karl

• PET kinetic analysis—compartmental model

  Citation: 163

  Authors: Hiroshi, Yoko, Yuichi, Mika, Miho

• Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease

  Citation: 161

  Authors: Hiroshi

• Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery —In malignant glioma—

  Citation: 158

  Authors: Naohiro, Toshihiro, Ichiro, Yoshiyasu, Kazuhiro, Kiyoaki, Misao, Kenji, Kenji, Michiharu, Akimasa, Mitsuhiro

• Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT

  Citation: 155

  Authors: Steven P., Michael A., Hans J., M., Hazem, Zsolt, Steve Y., Martin G., Mohamad E.

• Low density of sigma1 receptors in early Alzheimer’s disease

  Citation: 147

  Authors: Masahiro, Masashi, Kenji, Shin, Yuichi, Kei-ichi, Kazunori, Toru, Shiro, Yasuo, Kiichi

• FDG-PET in infectious lesions: The detection and assessment of lesion activity

  Citation: 143

  Authors: Yuichi, Yasuo, Masayuki, Tsuyoshi, Yuko, Sadayuki, Katsumasa, Toshimitsu, Kouji

• Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”—

  Citation: 141

  Authors: Tatsuya, Tsuneo, Yuji, Takayoshi, Koji, Ryuichiro, Masayuki, Junji

• SPECT and PET imaging in Alzheimer’s disease

  Citation: 136

  Authors: Varvara, Julia, John, Efthimios, Ioannis, Dimitrios, Sotiria, George, Panagiotis

---